↓ Skip to main content

Primary myelofibrosis: current therapeutic options

Overview of attention for article published in Hematology Transfusion and Cell Therapy, April 2016
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Primary myelofibrosis: current therapeutic options
Published in
Hematology Transfusion and Cell Therapy, April 2016
DOI 10.1016/j.bjhh.2016.04.003
Pubmed ID
Authors

Paula de Melo Campos

Abstract

Primary myelofibrosis is a Philadelphia-negative myeloproliferative neoplasm characterized by clonal myeloid expansion, followed by progressive fibrous connective tissue deposition in the bone marrow, resulting in bone marrow failure. Clonal evolution can also occur, with an increased risk of transformation to acute myeloid leukemia. In addition, disabling constitutional symptoms secondary to the high circulating levels of proinflammatory cytokines and hepatosplenomegaly frequently impair quality of life. Herein the main current treatment options for primary myelofibrosis patients are discussed, contemplating disease-modifying therapeutics in addition to palliative measures, in an individualized patient-based approach.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 22%
Student > Bachelor 5 19%
Student > Doctoral Student 4 15%
Other 3 11%
Student > Ph. D. Student 2 7%
Other 4 15%
Unknown 3 11%
Readers by discipline Count As %
Medicine and Dentistry 12 44%
Immunology and Microbiology 2 7%
Agricultural and Biological Sciences 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 4 15%
Unknown 5 19%